华润双鹤：盐酸替罗非班氯化钠注射液获药品注册证书

Core Viewpoint - China Resources Double Crane (华润双鹤) announced that its wholly-owned subsidiary, Anhui Double Crane, received a drug registration certificate from the National Medical Products Administration for the sodium chloride injection of Ticagrelor, which is an antiplatelet aggregation drug used for preventing early myocardial infarction in adult patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) [1] Company Summary - The drug is specifically indicated for adult patients experiencing chest pain within 12 hours and accompanied by ECG changes and/or elevated myocardial enzymes [1]